Effects of immunotherapies and prognostic predictors in neuromyelitis optica spectrum disorder: a prospective cohort study
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Effects of immunotherapies and prognostic predictors in neuromyelitis optica spectrum disorder: a prospective cohort study
Authors
Keywords
-
Journal
JOURNAL OF NEUROLOGY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-11-28
DOI
10.1007/s00415-019-09649-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Outcome prediction models in AQP4-IgG positive neuromyelitis optica spectrum disorders
- (2019) Jacqueline Palace et al. BRAIN
- Neurofilament light chain serum levels reflect disease severity in MOG-Ab associated disorders
- (2019) Sara Mariotto et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Diagnosis and management of neuromyelitis optica spectrum disorders - An update
- (2018) Alice Bruscolini et al. AUTOIMMUNITY REVIEWS
- Treating neuromyelitis optica with azathioprine: 20-year clinical practice
- (2018) Denis Bernardi Bichuetti et al. Multiple Sclerosis Journal
- Treating neuromyelitis optica with azathioprine: 20-year clinical practice
- (2018) Denis Bernardi Bichuetti et al. Multiple Sclerosis Journal
- Low-Dose Mycophenolate Mofetil for Treatment of Neuromyelitis Optica Spectrum Disorders: A Prospective Multicenter Study in South China
- (2018) Qiao Huang et al. Frontiers in Immunology
- Nationwide prevalence and incidence study of neuromyelitis optica spectrum disorder in Denmark
- (2018) Viktoria Papp et al. NEUROLOGY
- Racial differences in neuromyelitis optica spectrum disorder
- (2018) Su-Hyun Kim et al. NEUROLOGY
- Comparison of the efficacy of azathioprine and rituximab in neuromyelitis optica spectrum disorder: a randomized clinical trial
- (2017) Zahra Nikoo et al. JOURNAL OF NEUROLOGY
- Prognostic factors and disease course in aquaporin-4 antibody-positive Chinese patients with acute optic neuritis
- (2017) Hao Kang et al. JOURNAL OF NEUROLOGY
- Incidence and prevalence of NMOSD in Australia and New Zealand
- (2017) Wajih Bukhari et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Immunotherapies in neuromyelitis optica spectrum disorder: efficacy and predictors of response
- (2017) Jan-Patrick Stellmann et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Predictors of response to first-line immunosuppressive therapy in neuromyelitis optica spectrum disorders
- (2017) Su-Hyun Kim et al. Multiple Sclerosis Journal
- Prevalence and clinical features of neuromyelitis optica spectrum disorders in northern Japan
- (2017) Hideki Houzen et al. NEUROLOGY
- Predictors of response to first-line immunosuppressive therapy in neuromyelitis optica spectrum disorders
- (2017) Su-Hyun Kim et al. Multiple Sclerosis Journal
- Comparisons of the efficacy and tolerability of mycophenolate mofetil and azathioprine as treatments for neuromyelitis optica and neuromyelitis optica spectrum disorder
- (2016) H. Chen et al. EUROPEAN JOURNAL OF NEUROLOGY
- Comparative analysis of treatment outcomes in patients with neuromyelitis optica spectrum disorder using multifaceted endpoints
- (2015) In Hye Jeong et al. Multiple Sclerosis Journal
- Demographic and clinical features of neuromyelitis optica: A review
- (2015) L Pandit et al. Multiple Sclerosis Journal
- International consensus diagnostic criteria for neuromyelitis optica spectrum disorders
- (2015) Dean M. Wingerchuk et al. NEUROLOGY
- Comparative analysis of treatment outcomes in patients with neuromyelitis optica spectrum disorder using multifaceted endpoints
- (2015) In Hye Jeong et al. Multiple Sclerosis Journal
- Demographic and clinical features of neuromyelitis optica: A review
- (2015) L Pandit et al. Multiple Sclerosis Journal
- Long-term efficacy, tolerability and retention rate of azathioprine in 103 aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder patients: a multicentre retrospective observational study from the UK
- (2014) Liene Elsone et al. Multiple Sclerosis Journal
- Mycophenolate Mofetil in the Treatment of Neuromyelitis Optica Spectrum Disorder
- (2014) So-Young Huh et al. JAMA Neurology
- Comparison of Relapse and Treatment Failure Rates Among Patients With Neuromyelitis Optica
- (2014) Maureen A. Mealy et al. JAMA Neurology
- Utility of aquaporin-4 antibody assay in patients with neuromyelitis optica spectrum disorders
- (2013) Sung-Min Kim et al. Multiple Sclerosis Journal
- Characterization of neuromyelitis optica and neuromyelitis optica spectrum disorder patients with a late onset
- (2013) N Collongues et al. Multiple Sclerosis Journal
- Prognostic factors and disease course in aquaporin-4 antibody-positive patients with neuromyelitis optica spectrum disorder from the United Kingdom and Japan
- (2012) Joanna Kitley et al. BRAIN
- Azathioprine: Tolerability, efficacy, and predictors of benefit in neuromyelitis optica
- (2011) C. Costanzi et al. NEUROLOGY
- Standardized method for the detection of antibodies to aquaporin-4 based on a highly sensitive immunofluorescence assay employing recombinant target antigen
- (2010) S. Jarius et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Treatment of Neuromyelitis Optica With Mycophenolate Mofetil
- (2009) Anu Jacob et al. ARCHIVES OF NEUROLOGY
- Relapsing neuromyelitis optica: long term history and clinical predictors of death
- (2009) P Cabre et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now